A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. (Q48692643)

From Wikidata

Jump to navigation Jump to search

scientific article published in July 1991

edit

Language	Label	Description	Also known as
English	A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.	scientific article published in July 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

title

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

main subject

adaptive radiation therapy

0 references

chemotherapy

1 reference

based on heuristic

inferred from title

astrocytoma

1 reference

based on heuristic

inferred from title

procarbazine

1 reference

based on heuristic

inferred from title

author name string

Sandberg-Wollheim M

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Malmström P

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Strömblad LG

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Anderson H

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Borgström S

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Brun A

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Cronqvist S

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Hougaard K

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

Salford LG

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

language of work or name

English

0 references

publication date

1 July 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

volume

68

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

page(s)

22-29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

cites work

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2819910701%2968%3A1%3C22%3A%3AAID-CNCR2820680105%3E3.0.CO%3B2-2

retrieved

21 January 2018

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2819910701%2968%3A1%3C22%3A%3AAID-CNCR2820680105%3E3.0.CO%3B2-2

retrieved

21 January 2018

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F1097-0142%2819910701%2968%3A1%3C22%3A%3AAID-CNCR2820680105%3E3.0.CO%3B2-2

retrieved

21 January 2018

Identifiers

DOI

10.1002/1097-0142(19910701)68:1<22::AID-CNCR2820680105>3.0.CO;2-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

PubMed publication ID

2049748

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2049748

retrieved

14 February 2018

reference URL

http://europepmc.org/abstract/MED/2049748

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48692643&oldid=1775811633"